Every journey is different. We’re here for yours.

Psychedelic-assisted therapy for
cancer, PTSD, depression, and trauma.

At Sunstone Therapies, we guide patients through psychedelic-assisted therapy in a safe, structured clinical trial setting. Our care teams include licensed therapists, physicians, and facilitators trained in trauma, end-of-life care, and complex mental health conditions.
Explore Our Clinical Trials

Advancing Psychedelic Therapy Through Clinical Research

Sunstone Therapies conducts clinical trials in psychedelic-assisted therapy for patients facing complex mental health challenges. Our work is grounded in research and delivered by trained medical teams in a safe, structured setting.
Psychedelic-Assisted Therapy
Clinical Trials
Published Research
Patient Experience
Centers for Healing
Partnerships
Patient Support Resources

Expertise Informed by Experience

Sunstone is guided by a team of Clinical Research Coordinators with over 30 years of combined clinical expertise and over 5 years of specialized experience in psychedelic research.

We are currently offering trials to address depression, treatment-resistant depression, postpartum depression, cancer and depression, adjustment disorder, and PTSD. These trials use a variety of psychedelic compounds including, but not limited to psilocybin, MDMA, and 5-MeO-DMT.

Explore Open Studies
  • Adjustment Disorder (AD)
  • Advanced Illness
  • Generalized Anxiety Disorder
  • Major Depressive Disorder (MDD)
  • MDD and Cancer
  • Post-Traumatic Stress Disorder 
  • Postpartum Depression
  • Treatment-Resistant Depression
  • Psilocybin 
  • MDMA
  • LSD
  • 5-MeO-DMT
  • Methylone
  • RE-104 (novel serotonergic antidepressant)
  • atai Life Sciences
  • Beckley Psytech
  • Compass Pathways 
  • Cybin 
  • Lykos Therapeutics
  • Reunion Neuroscience 
  • Transcend Therapeutics
  • Usona Institute 
  • Adventist HealthCare
  • Dana-Farber Cancer Institute
  • Johns Hopkins Center for Psychedelic &
    Consciousness Research
  • McGill University 
  • Memorial Sloan Kettering Cancer Center 
  • The University of Vermont 

Participating in a clinical trial at Sunstone contributes to advancing scientific knowledge in the field of mental health research. Sunstone’s clinical team has authored 11 papers on psychedelic research in leading journals, including Cancer, JAMA Oncology, and NIH-Heals. 

View Published Research
Learn More
Our Mission

Our Mission

Sunstone is establishing the gold standard for psychedelic clinics to deliver care that reduces the emotional suffering of those affected by complex mental health challenges and disorders, and to make safe, effective psychedelic-assisted therapy accessible.
Whole Person Healing is

New Clinical Study Enrolling for Major Depressive DisorderLearn More
+